Our research is centered on the development of bioprocesses for complex biopharmaceuticals namely vaccines, recombinant proteins and viral vectors for gene therapy. Current efforts include also the development of tools and methodologies for cell therapy applications and pre-clinical research (novel 3D in vitro models for liver, cardiac- and neuro-toxicology, through the use of human stem cells and primary cultures of human hepatocytes).